Talarico, Marco; Vischini, Gisella; Barbato, Simona; Restuccia, Roberta; Masci, Simone; Sacchetti, Ilaria; Manzato, Enrica; Ghibellini, Stefano; Puppi, Michele; Iezza, Miriam; Rizzello, Ilaria; Pantani, Lucia; Tacchetti, Paola; Borsi, Enrica; Solli, Vincenza; Terragna, Carolina; Agostinelli, Claudio; La Manna, Gaetano; Cavo, Michele; Zamagni, Elena; Mancuso, Katia, Case Report: Uncommon co-occurrence of different renal histopathological entities in a patient with multiple myeloma and lymphoplasmacytic lymphoma, «FRONTIERS IN ONCOLOGY», 2025, 15, pp. 1 - 7 [articolo]
Mancuso, K.; Barbato, S.; Raimondo, F. D.; Gay, F.; Musto, P.; Offidani, M.; Petrucci, M. T.; Zamagni, E.; Zambello, R.; Cavo, M., Correction: Forcing Ahead: Second-Line Treatment Options for Lenalidomide-Refractory Multiple Myeloma, «CANCERS», 2025, 17, pp. 1168 - 1168 [articolo]
Talarico, M.; Barbato, S.; Cattabriga, A.; Sacchetti, I.; Manzato, E.; Restuccia, R.; Masci, S.; Bigi, F.; Puppi, M.; Iezza, M.; Rizzello, I.; Mancuso, K.; Pantani, L.; Tacchetti, P.; Nanni, C.; Cavo, M.; Zamagni, E., Diagnostic Innovations: Advances in imaging techniques for diagnosis and follow-up of multiple myeloma, «JOURNAL OF BONE ONCOLOGY», 2025, 51, Article number: 100669, pp. 1 - 12 [articolo]Open Access
Musto, P.; Engelhardt, M.; van de Donk, N. W. C. J.; Gay, F.; Terpos, E.; Einsele, H.; Fernández de Larrea, C.; Sgherza, N.; Bolli, N.; Katodritou, E.; Gentile, M.; Royer, B.; Derudas, D.; Jelinek, T.; Zamagni, E.; Rosiñol, L.; Paiva, B.; Caers, J.; Kaiser, M.; Beksac, M.; Hájek, R.; Spencer, A.; Ludwig, H.; Cavo, M.; Bladé, J.; Moreau, P.; Mateos, M. V.; San-Miguel, J. F.; Dimopoulos, M. A.; Boccadoro, M.; Sonneveld, P., European Myeloma Network Group review and consensus statement on primary plasma cell leukemia, «ANNALS OF ONCOLOGY», 2025, 36, pp. 361 - 374 [articolo]Open Access
Talarico, M.; Barbato, S.; Maisnar, V.; Delimpasi, S.; Puppi, M.; Rizzello, I.; Pantani, L.; Tacchetti, P.; Martello, M.; Vigliotta, I.; Terragna, C.; Cavo, M.; Zamagni, E.; Mancuso, K., Exceptional long-term responses from OCEAN and HORIZON trials: melflufen-dexamethasone as an expansion of treatment options for relapsed/refractory multiple myeloma in the era of new immunotherapies?, «JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY», 2025, 151, pp. 288 - 288 [articolo]
Mancuso, K.; Barbato, S.; Di Raimondo, F.; Gay, F.; Musto, P.; Offidani, M.; Petrucci, M. T.; Zamagni, E.; Zambello, R.; Cavo, M., Forcing Ahead: Second-Line Treatment Options for Lenalidomide-Refractory Multiple Myeloma, «CANCERS», 2025, 17, pp. 1168 - 1168 [articolo]
Salvestrini, Valentina; Conti, Gabriele; D'Amico, Federica; Cristiano, Gianluca; Candela, Marco; Cavo, Michele; Turroni, Silvia; Curti, Antonio, Gut Microbiome as a Potential Marker of Hematologic Recovery Following Induction Therapy in Acute Myeloid Leukemia Patients, «CANCER MEDICINE», 2025, 14, Article number: e70501, pp. 1 - 13 [articolo]Open Access
Mancuso, Katia; Barbato, Simona; Talarico, Marco; Tacchetti, Paola; Zamagni, Elena; Cavo, Michele, Idecabtagene vicleucel (ide-cel) for the treatment of triple-class exposed relapsed and refractory multiple myeloma, «EXPERT OPINION ON BIOLOGICAL THERAPY», 2025, 25, pp. 27 - 46 [articolo]Open Access
Mancuso, K.; Talarico, M.; Manzato, E.; Barbato, S.; Tacchetti, P.; Zamagni, E.; Cavo, M., T-Cell Redirecting Therapies in Multiple Myeloma: Pathogenesis and Management of Toxicities Beyond CRS and ICANS, «CANCERS», 2025, 17, Article number: 1514, pp. 1514 - 1514 [articolo]
Bigi, F.; Fiacchini, M.; Restuccia, R.; Masci, S.; Mazzocchetti, G.; Talarico, M.; Puppi, M.; Sacchetti, I.; Manzato, E.; Iezza, M.; Mancuso, K.; Sartor, C.; Pantani, L.; Tacchetti, P.; Alatif, R. A.; Pastore, E.; Barbato, S.; Cavo, M.; Zamagni, E.; Rizzello, I., Ten-year experience on home care for patients with plasma cell disorders: bringing optimal therapy home, «CLINICAL AND EXPERIMENTAL MEDICINE», 2025, 25, pp. 179 - 179 [articolo]
Poletti, A; Taurisano, B; Mazzocchetti, G; Lionetti, M; Martello, M; Vuong, Vm; Solli, V; Marzocchi, G; Maeda, A; Vigliotta, I; Borsi, E; Armuzzi, S; Pistis, I; Marella, A; Fabris, S; Tacchetti, P; Mancuso, K; Rizzello, I; Pantani, L; Testoni, N; Cavo, M; Zamagni, E; Bolli, N; Terragna, C., Unique molecular assay (UMA): a next-generation sequencing targeted panel for efficient and comprehensive genomic profiling and risk stratification of multiple myeloma, «HAEMATOLOGICA», 2025, Early View, pp. 1 - 16 [articolo]Open Access
Tacchetti, P.; Talarico, M.; Barbato, S.; Pantani, L.; Mancuso, K.; Rizzello, I.; Zamagni, E.; Cavo, M., Antibody-drug conjugates, bispecific antibodies and CAR-T cells therapy in multiple myeloma, «EXPERT REVIEW OF ANTICANCER THERAPY», 2024, 24, pp. 379 - 395 [articolo]
Hungria, V.; Robak, P.; Hus, M.; Zherebtsova, V.; Ward, C.; Ho, P. J.; Ribas de Almeida, A. C.; Hajek, R.; Kim, K.; Grosicki, S.; Sia, H.; Bryant, A.; Pitombeira de Lacerda, M.; Martinez, G. A.; Balari, A. M. S.; Sandhu, I.; Cerchione, C.; Ganly, P.; Dimopoulos, M.; Fu, C.; Garg, M.; Abdallah, A. -O.; Oriol, A.; Gatt, M. E.; Cavo, M.; Rifkin, R.; Fujisaki, T.; Mielnik, M.; Pirooz, N.; Mckeown, A.; Mcnamara, S.; Zhou, X.; Nichols, M.; Lewis, E.; Rogers, R.; Baig, H.; Eccersley, L.; Roy-Ghanta, S.; Opalinska, J.; Mateos, M. -V., Belantamab Mafodotin, Bortezomib, and Dexamethasone for Multiple Myeloma, «THE NEW ENGLAND JOURNAL OF MEDICINE», 2024, 391, pp. 393 - 407 [articolo]
Dimopoulos, M. A.; Beksac, M.; Pour, L.; Delimpasi, S.; Vorobyev, V.; Quach, H.; Spicka, I.; Radocha, J.; Robak, P.; Kim, K.; Cavo, M.; Suzuki, K.; Morris, K.; Pompilus, F.; Phillips-Jones, A.; Zhou, X. L.; Fulci, G.; Sule, N.; Kremer, B. E.; Opalinska, J.; Mateos, M. -V.; Trudel, S., Belantamab Mafodotin, Pomalidomide, and Dexamethasone in Multiple Myeloma, «THE NEW ENGLAND JOURNAL OF MEDICINE», 2024, 391, pp. 408 - 421 [articolo]
Mateos, Maria Victoria; Weisel, Katja; Terpos, Evangelos; Delimpasi, Sossana; Kastritis, Efstathios; Zamagni, Elena; Delforge, Michel; Ocio, Enrique; Katodritou, Eirini; Gay, Francesca; Larocca, Alessandra; Leleu, Xavier; Otero, Paula Rodriguez; Schjesvold, Fredik; Cavo, Michele; Dimopoulos, Meletios A., Belantamab mafodotin: an important treatment option for vulnerable patients with triple class exposed relapsed and/or refractory multiple myeloma, «HAEMATOLOGICA», 2024, 109, pp. 2337 - 2340 [articolo]Open Access
